wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48275281-92AC6A4A-E36B-4FEC-8095-596E6E424CE7
Q48275281-92AC6A4A-E36B-4FEC-8095-596E6E424CE7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48275281-92AC6A4A-E36B-4FEC-8095-596E6E424CE7
Long-term treatment with bosutinib in a phase 1/2 study in Japanese chronic myeloid leukemia patients resistant/intolerant to prior tyrosine kinase inhibitor treatment.
P2860
Q48275281-92AC6A4A-E36B-4FEC-8095-596E6E424CE7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48275281-92AC6A4A-E36B-4FEC-8095-596E6E424CE7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d0c0d325e00624a5df1d50b4875411930aa7ba0a
P2860
Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up.